Ascendis Pharma A/S
NASDAQ:ASND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ascendis Pharma A/S
NASDAQ:ASND
|
DK |
|
CF Industries Holdings Inc
NYSE:CF
|
US |
|
C
|
Capita PLC
F:CTAA
|
UK |
|
TP ICAP PLC
LSE:TCAP
|
UK |
|
Acousort AB
F:4SA
|
SE |
|
H2APEX Group SCA
F:H2A
|
LU |
|
Dassault Aviation SA
F:DAU0
|
FR |
Wall St Price Targets
ASND Price Targets Summary
Ascendis Pharma A/S
According to Wall Street analysts, the average 1-year price target for ASND is 305.57 USD with a low forecast of 258.56 USD and a high forecast of 372.75 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ASND's stock price target?
Price Target
305.57
USD
According to Wall Street analysts, the average 1-year price target for ASND is 305.57 USD with a low forecast of 258.56 USD and a high forecast of 372.75 USD.
What is the Revenue forecast for Ascendis Pharma A/S?
Projected CAGR
24%
Over the last 12 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 24%.
What is the Gross Profit forecast for Ascendis Pharma A/S?
Projected CAGR
25%
The compound annual growth rate for Gross Profit over the next 8 years is 25%.
